These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 17851087

  • 21. Circadian pattern of spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
    Eksik A, Akyol A, Norgaz T, Aksu H, Erdinler I, Cakmak N, Alper AT, Cinar B, Yildirim A, Gürkan K.
    Med Sci Monit; 2007 Sep; 13(9):CR412-416. PubMed ID: 17767121
    [Abstract] [Full Text] [Related]

  • 22. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R, Mitrache A, Quan W, Cohen TJ.
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [Abstract] [Full Text] [Related]

  • 23. Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator.
    Elgarhi N, Kreuz J, Balta O, Nickenig G, Hoium H, Lewalter T, Schwab JO.
    Heart; 2008 Apr; 94(4):e16. PubMed ID: 17639096
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 26. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W, Hoffmann J Jü, Müller HH, Maisch B.
    J Am Coll Cardiol; 2002 Mar 06; 39(5):780-7. PubMed ID: 11869841
    [Abstract] [Full Text] [Related]

  • 27. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?
    Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson JW, Sheldon T.
    J Am Coll Cardiol; 2007 Aug 14; 50(7):614-22. PubMed ID: 17692746
    [Abstract] [Full Text] [Related]

  • 28. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.
    Am J Cardiol; 2009 Jul 01; 104(1):128-32. PubMed ID: 19576333
    [Abstract] [Full Text] [Related]

  • 29. Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Zhou X, Gunderson BD, Olson WH, Gem DR ICD Clinical Worldwide Investigators.
    J Cardiovasc Electrophysiol; 2004 Jan 01; 15(1):14-20. PubMed ID: 15028067
    [Abstract] [Full Text] [Related]

  • 30. Timing of life-threatening arrhythmias detected by implantable cardioverter-defibrillators in relation to changes in cosmophysical factors.
    Stoupel E, Kusniec J, Mazur A, Abramson E, Israelevich P, Strasberg B.
    Cardiol J; 2008 Jan 01; 15(5):437-40. PubMed ID: 18810718
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F, Kuschyk J, Dietrich C, Mahl E, Streitner I, Doesch C, Veltmann C, Schimpf R, Wolpert C, Borggrefe M.
    Clin Cardiol; 2011 Oct 01; 34(10):604-9. PubMed ID: 21887690
    [Abstract] [Full Text] [Related]

  • 34. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME, TIMI Study Group.
    J Am Coll Cardiol; 2008 Feb 05; 51(5):546-51. PubMed ID: 18237683
    [Abstract] [Full Text] [Related]

  • 35. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C, Zhu AX, Vanheel L, Sakaguchi RN, Lurie KG, Lu F, Benditt DG.
    Europace; 2007 May 05; 9(5):270-4. PubMed ID: 17371804
    [Abstract] [Full Text] [Related]

  • 36. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
    Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F.
    J Heart Lung Transplant; 2009 Jul 05; 28(7):733-5. PubMed ID: 19560703
    [Abstract] [Full Text] [Related]

  • 37. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm.
    Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, Burkhardt JD, Belden WA, Cummings JE, Abdul-Karim A, Saliba W, Schweikert RA, Tchou PJ, Martin DO, Natale A.
    J Cardiovasc Electrophysiol; 2004 Nov 05; 15(11):1265-70. PubMed ID: 15574176
    [Abstract] [Full Text] [Related]

  • 38. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia.
    Ngaage DL, Cale AR, Cowen ME, Griffin S, Guvendik L.
    Ann Thorac Surg; 2008 Apr 05; 85(4):1278-81. PubMed ID: 18355509
    [Abstract] [Full Text] [Related]

  • 39. [Circadian and weekly distribution of malignant ventricular arrhythmias in patients with coronary heart disease or dilatative cardiomyopathy who have an implanted cardioverter-defibrillator].
    Wolpert C, Jung W, Spehl S, Schumacher B, Omran H, Schimpf R, Lüderitz B.
    Dtsch Med Wochenschr; 1998 Feb 06; 123(6):140-5. PubMed ID: 9505952
    [Abstract] [Full Text] [Related]

  • 40. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.
    Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, EMPIRIC Trial Investigators.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):330-9. PubMed ID: 16843184
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.